These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19177457)

  • 1. Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.
    Margraf RL; Crockett DK; Krautscheid PM; Seamons R; Calderon FR; Wittwer CT; Mao R
    Hum Mutat; 2009 Apr; 30(4):548-56. PubMed ID: 19177457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG/AMP variant classification guidelines and impact on the MEN2 RET database.
    Margraf RL; Alexander RZ; Fulmer ML; Miller CE; Coupal E; Mao R
    Hum Mutat; 2022 Dec; 43(12):1780-1794. PubMed ID: 36251279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
    Vanhorne JB; Andrew SD; Harrison KJ; Taylor SA; Thomas B; McDonald TJ; Ainsworth PJ; Mulligan LM
    Oncogene; 2005 Feb; 24(6):1091-7. PubMed ID: 15592530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
    Machens A; Dralle H
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular advances in medullary thyroid cancer diagnostics.
    Hubner RA; Houlston RS
    Clin Chim Acta; 2006 Aug; 370(1-2):2-8. PubMed ID: 16519882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene.
    Calderon FR; Phansalkar AR; Crockett DK; Miller M; Mao R
    Hum Mutat; 2007 Oct; 28(10):939-43. PubMed ID: 17486650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.
    Mise N; Drosten M; Racek T; Tannapfel A; Pützer BM
    Oncogene; 2006 Oct; 25(50):6637-47. PubMed ID: 16715139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN2 screening dilemmas in a family with a novel RET mutation in the MEN2 susceptibility region of the gene, a family history of Hirschsprung disease, and no family history of MEN2-related tumours.
    Clowes VE; Shaw-Smith C; Simpson H; Ball SG; Acerini CL
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):666-7. PubMed ID: 17877758
    [No Abstract]   [Full Text] [Related]  

  • 12. [RET gene cys 634 trp mutation in a multiple endocrine neoplasia type 2A kindred].
    Ning ZW; Wang O; Pei Y; Meng XW; Xing XP; Xia WB; Li M; Zhou XY; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):799-802. PubMed ID: 17260470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)].
    Yao B; Liu X; Dong TT; Chen X; Huang ZM; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1962-5. PubMed ID: 17923033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RET Protooncogene.
    Traugott AL; Moley JF
    Cancer Treat Res; 2010; 153():303-19. PubMed ID: 19957232
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and molecular aspects of multiple endocrine neoplasia.
    Wick MJ
    Clin Lab Med; 1997 Mar; 17(1):39-57. PubMed ID: 9138898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ret-protooncogene mutation, verified by molecular genetic methods, in a Hungarian MEN Type 2a family].
    Igaz P; Rácz K; Tóth M; Cserepes E; Esik O; Kiss R; Perner F; Gláz E; Tulassay Z
    Orv Hetil; 1999 Feb; 140(7):355-7. PubMed ID: 10091505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease.
    Moore SW; Zaahl M
    J Pediatr Surg; 2009 Oct; 44(10):1899-903. PubMed ID: 19853744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human FOXL2 mutation database.
    Beysen D; Vandesompele J; Messiaen L; De Paepe A; De Baere E
    Hum Mutat; 2004 Sep; 24(3):189-93. PubMed ID: 15300845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of multiple endocrine neoplasies: clinical implications].
    Igaz P; Gaillard RC
    Rev Med Suisse; 2005 Feb; 1(6):408-13. PubMed ID: 15786644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Hyperparathyroidism in MEN2 Syndromes.
    Alevizaki M; Saltiki K
    Recent Results Cancer Res; 2015; 204():179-86. PubMed ID: 26494389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.